Fingerprint
Dive into the research topics of 'North central cancer treatment group (NCCTG) N0537: Phase II trial of vegf-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically